Covered recipient · General Payments record
GARFIELD H SAMUELS
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2023
$12,415.73
- Reported across 703 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $412.60 | 11 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $271.00 | 4 |
| Lilly USA, LLC | $48.92 | 2 |
| ABBVIE INC. | $32.95 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $25.73 | 1 |
| SANOFI-AVENTIS U.S. LLC | $19.57 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $14.43 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AbbVie Inc. | $16.00 | 01/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998804205 | CMS |
| AbbVie Inc. | $16.95 | 02/28/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998804211 | CMS |
| Amgen Inc. | $10.95 | 01/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1020580201 | CMS |
| Amgen Inc. | $125.22 | 02/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1020580205 | CMS |
| Amgen Inc. | $14.23 | 02/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1020580203 | CMS |
| Amgen Inc. | $120.60 | 09/26/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1019912957 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $25.73 | 02/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996461613 | CMS |
| Lilly USA, LLC | $17.61 | 01/25/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031396157 | CMS |
| Lilly USA, LLC | $31.31 | 01/31/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031379627 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $14.43 | 01/25/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1057202353 | CMS |
| SANOFI-AVENTIS U.S. LLC | $19.57 | 01/30/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1050266743 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.